Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome

Clinical trial NCT03708900 · RECRUITING

Trial details

NCT number: NCT03708900
Sponsor: RECORDATI GROUP
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cushing Syndrome

Start date: 2021-04-28
Primary completion: 2027-07-21
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.